PolyPeptide Group AG (PPGN) — Cash Flow Reinvestment Rate
PolyPeptide Group AG (PPGN) has a Cash Flow Reinvestment Rate of 0.98x as of June 2025, reinvesting CHF48.68 Million (capex CHF48.68 Million ) from operating cash flow of CHF49.66 Million. See PPGN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PolyPeptide Group AG Cash Flow Reinvestment Rate (2018–2024)
Historical reinvestment intensity for PolyPeptide Group AG across 7 annual periods. For the full cash flow conversion analysis, see how efficiently does PolyPeptide Group AG generate cash.
Annual Cash Flow Reinvestment Rate for PolyPeptide Group AG (2018–2024)
Year-by-year capital reinvestment analysis for PolyPeptide Group AG. See PolyPeptide Group AG (PPGN) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.99x | CHF177.99 Million | CHF89.40 Million | CHF86.97 Million | ▼ -37.5% |
| 2023 | 3.19x | CHF116.25 Million | CHF36.48 Million | CHF56.73 Million | ▼ -88.9% |
| 2022 | 28.79x | CHF157.20 Million | CHF5.46 Million | CHF78.76 Million | ▲ +1939.4% |
| 2021 | 1.41x | CHF80.97 Million | CHF57.35 Million | CHF77.71 Million | ▲ +70.9% |
| 2020 | 0.83x | CHF40.88 Million | CHF49.48 Million | CHF40.62 Million | ▲ +102.3% |
| 2019 | 0.41x | CHF22.70 Million | CHF55.60 Million | CHF19.70 Million | ▼ -49.6% |
| 2018 | 0.81x | CHF18.59 Million | CHF22.94 Million | CHF18.30 Million | — |